165 related articles for article (PubMed ID: 26329581)
21. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
Sørensen CS; Lukas C; Kramer ER; Peters JM; Bartek J; Lukas J
Mol Cell Biol; 2001 Jun; 21(11):3692-703. PubMed ID: 11340163
[TBL] [Abstract][Full Text] [Related]
22. Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.
Kubic JD; Young KP; Plummer RS; Ludvik AE; Lang D
Pigment Cell Melanoma Res; 2008 Dec; 21(6):627-45. PubMed ID: 18983540
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of PAX3 contributes to melanoma phenotypes by affecting proliferation, invasion, and transformation.
Iyengar AS; Miller PJ; Loupe JM; Hollenbach AD
Pigment Cell Melanoma Res; 2014 Sep; 27(5):846-8. PubMed ID: 24903325
[No Abstract] [Full Text] [Related]
24. PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).
Medic S; Ziman M
PLoS One; 2010 Apr; 5(4):e9977. PubMed ID: 20421967
[TBL] [Abstract][Full Text] [Related]
25. PAX3 Is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans.
He S; Yoon HS; Suh BJ; Eccles MR
J Invest Dermatol; 2010 May; 130(5):1465-8. PubMed ID: 20107488
[No Abstract] [Full Text] [Related]
26. New Functions of APC/C Ubiquitin Ligase in the Nervous System and Its Role in Alzheimer's Disease.
Fuchsberger T; Lloret A; Viña J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28505105
[TBL] [Abstract][Full Text] [Related]
27. Nuclear focal adhesion kinase induces APC/C activator protein CDH1-mediated cyclin-dependent kinase 4/6 degradation and inhibits melanoma proliferation.
Murphy JM; Jeong K; Ahn EE; Lim SS
J Biol Chem; 2022 Jun; 298(6):102013. PubMed ID: 35525274
[TBL] [Abstract][Full Text] [Related]
28. Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis.
Han T; Jiang S; Zheng H; Yin Q; Xie M; Little MR; Yin X; Chen M; Song SJ; Beg AA; Pandolfi PP; Wan L
Nat Commun; 2019 Aug; 10(1):3716. PubMed ID: 31420536
[TBL] [Abstract][Full Text] [Related]
29. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
[TBL] [Abstract][Full Text] [Related]
30. Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.
Bosserhoff AK; Ellmann L; Kuphal S
Exp Dermatol; 2011 May; 20(5):435-40. PubMed ID: 21496114
[TBL] [Abstract][Full Text] [Related]
31. Haplosufficiency of PAX3 for melanoma development in Tyr: NRASQ61K; Cdkn2a-/- mice allows identification and sorting of melanoma cells using a Pax3GFP reporter allele.
Campagne C; Reyes-Gomez E; Loiodice S; Gadin S; Ezagal J; Bernex F; Abitbol M; Louise A; Beermann F; Panthier JJ; Aubin-Houzelstein G; Egidy G
Melanoma Res; 2016 Feb; 26(1):12-20. PubMed ID: 26587692
[TBL] [Abstract][Full Text] [Related]
32. Anaphase-promoting complex/cyclosome controls the stability of TPX2 during mitotic exit.
Stewart S; Fang G
Mol Cell Biol; 2005 Dec; 25(23):10516-27. PubMed ID: 16287863
[TBL] [Abstract][Full Text] [Related]
33. Acm1 is a negative regulator of the CDH1-dependent anaphase-promoting complex/cyclosome in budding yeast.
Martinez JS; Jeong DE; Choi E; Billings BM; Hall MC
Mol Cell Biol; 2006 Dec; 26(24):9162-76. PubMed ID: 17030612
[TBL] [Abstract][Full Text] [Related]
34. PAX3 expression in primary melanomas and nevi.
Plummer RS; Shea CR; Nelson M; Powell SK; Freeman DM; Dan CP; Lang D
Mod Pathol; 2008 May; 21(5):525-30. PubMed ID: 18327212
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of APC-mediated proteolysis by the meiosis-specific protein kinase Ime2.
Bolte M; Steigemann P; Braus GH; Irniger S
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4385-90. PubMed ID: 11917129
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
Tatzel J; Poser I; Schroeder J; Bosserhoff AK
Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
[TBL] [Abstract][Full Text] [Related]
37. Pax3 transcripts in melanoblast development.
Blake JA; Ziman MR
Dev Growth Differ; 2005 Dec; 47(9):627-35. PubMed ID: 16316407
[TBL] [Abstract][Full Text] [Related]
38. Methods to measure ubiquitin-dependent proteolysis mediated by the anaphase-promoting complex.
Kraft C; Gmachl M; Peters JM
Methods; 2006 Jan; 38(1):39-51. PubMed ID: 16343932
[TBL] [Abstract][Full Text] [Related]
39. Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.
Goldstein NB; Koster MI; Hoaglin LG; Spoelstra NS; Kechris KJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA
J Invest Dermatol; 2015 Aug; 135(8):2068-2076. PubMed ID: 25822579
[TBL] [Abstract][Full Text] [Related]
40. GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.
Kubic JD; Mascarenhas JB; Iizuka T; Wolfgeher D; Lang D
Mol Cancer Res; 2012 Aug; 10(8):1065-76. PubMed ID: 22679108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
